News - Clinical Trials Arena https://www.clinicaltrialsarena.com/news/ Hard data and deep insights on clinical trials strategy & operations Mon, 11 Nov 2024 07:55:55 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2022/01/cropped-Clinical-Trials-Arena-32x32.png News - Clinical Trials Arena https://www.clinicaltrialsarena.com/news/ 32 32 Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours https://www.clinicaltrialsarena.com/news/palleon-phase-i-ii-e-602/ Mon, 11 Nov 2024 07:55:11 +0000 https://www.clinicaltrialsarena.com/news/palleon-phase-i-ii-e-602/ Palleon has reported the outcomes from its Phase I/II study of E-602 with PD-1 inhibitor cemiplimab to treat patients with solid tumours.

The post Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours appeared first on Clinical Trials Arena.

]]>
The post Palleon Pharmaceuticals reports Phase I/II trial results of E-602 for solid tumours appeared first on Clinical Trials Arena.

]]>
Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment https://www.clinicaltrialsarena.com/news/hurricane-helene-delays-spectral-medicals-confirmatory-trial-enrolment/ Fri, 08 Nov 2024 15:56:38 +0000 https://www.clinicaltrialsarena.com/uncategorized/hurricane-helene-delays-spectral-medicals-confirmatory-trial-enrolment/ Spectral aims to finalise enrolment in early 2025 for its septic shock treatment Toraymyxin.

The post Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment appeared first on Clinical Trials Arena.

]]>
The post Hurricane Helene delays Spectral Medical’s confirmatory trial enrolment appeared first on Clinical Trials Arena.

]]>
OncoResponse reports data from Phase I solid tumour treatment trial https://www.clinicaltrialsarena.com/news/oncoresponse-phase-i-trial/ Fri, 08 Nov 2024 14:28:51 +0000 https://www.clinicaltrialsarena.com/news/oncoresponse-phase-i-trial/ OncoResponse has unveiled the outcomes from the Phase I trial of OR502 for treating advanced solid tumours.

The post OncoResponse reports data from Phase I solid tumour treatment trial appeared first on Clinical Trials Arena.

]]>
The post OncoResponse reports data from Phase I solid tumour treatment trial appeared first on Clinical Trials Arena.

]]>
AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial https://www.clinicaltrialsarena.com/news/astrazeneca-and-amgens-tezspire-succeeds-in-phase-iii-nasal-polyps-trial/ Fri, 08 Nov 2024 11:44:06 +0000 https://www.clinicaltrialsarena.com/news/astrazeneca-and-amgens-tezspire-succeeds-in-phase-iii-nasal-polyps-trial/ The companies’ monoclonal antibody met co-primary endpoints in a Phase III trial in patients with chronic rhinosinusitis with nasal polyps.

The post AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial appeared first on Clinical Trials Arena.

]]>
The post AstraZeneca and Amgen’s Tezspire succeeds in Phase III nasal polyps trial appeared first on Clinical Trials Arena.

]]>
Cofactor’s cancer biomarker test outshines standard ICI predictive tests   https://www.clinicaltrialsarena.com/news/cofactors-cancer-biomarker-test-outshines-standard-ici-predictive-tests/ Fri, 08 Nov 2024 11:32:10 +0000 https://www.clinicaltrialsarena.com/uncategorized/cofactors-cancer-biomarker-test-outshines-standard-ici-predictive-tests/ The test improved prediction of patient benefit from anti-PD-1 immune checkpoint inhibitors (ICIs) as a monotherapy and with chemotherapy.

The post Cofactor’s cancer biomarker test outshines standard ICI predictive tests   appeared first on Clinical Trials Arena.

]]>
The post Cofactor’s cancer biomarker test outshines standard ICI predictive tests   appeared first on Clinical Trials Arena.

]]>
Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain https://www.clinicaltrialsarena.com/news/averitas-trial-qutenza/ Fri, 08 Nov 2024 10:55:52 +0000 https://www.clinicaltrialsarena.com/news/averitas-trial-qutenza/ Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 study of QUTENZA to treat PSNP.

The post Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain appeared first on Clinical Trials Arena.

]]>
The post Averitas completes recruitment for trial of QUTENZA to treat post-surgical pain appeared first on Clinical Trials Arena.

]]>
Radella reports positive outcomes from trial of MD-18 for obesity and diabetes https://www.clinicaltrialsarena.com/news/radella-trial-md-18/ Fri, 08 Nov 2024 09:58:56 +0000 https://www.clinicaltrialsarena.com/news/radella-trial-md-18/ Radella Pharmaceuticals has reported topline outcomes from a Phase Ia trial that assessed an investigational therapy for obesity and diabetes.

The post Radella reports positive outcomes from trial of MD-18 for obesity and diabetes appeared first on Clinical Trials Arena.

]]>
The post Radella reports positive outcomes from trial of MD-18 for obesity and diabetes appeared first on Clinical Trials Arena.

]]>
Minister for Science champions partnerships with private clinical sector in UK https://www.clinicaltrialsarena.com/news/minister-for-science-champions-partnerships-with-private-clinical-sector-in-uk/ Thu, 07 Nov 2024 17:17:02 +0000 https://www.clinicaltrialsarena.com/uncategorized/minister-for-science-champions-partnerships-with-private-clinical-sector-in-uk/ Lord Vallance stated the government sees investment, innovation, and public-private partnership as crucial to UK healthcare.

The post Minister for Science champions partnerships with private clinical sector in UK appeared first on Clinical Trials Arena.

]]>
The post Minister for Science champions partnerships with private clinical sector in UK appeared first on Clinical Trials Arena.

]]>
Vidac secures funding to advance skin cancer trials of novel ointment https://www.clinicaltrialsarena.com/news/vidac-secures-funding-to-advance-skin-cancer-trials-of-novel-ointment/ Thu, 07 Nov 2024 16:03:29 +0000 https://www.clinicaltrialsarena.com/news/vidac-secures-funding-to-advance-skin-cancer-trials-of-novel-ointment/ Vidac will use the new funds to initiate a Phase IIb trial of its lead candidate VDA-1102 in patients with actinic keratosis.

The post Vidac secures funding to advance skin cancer trials of novel ointment appeared first on Clinical Trials Arena.

]]>
The post Vidac secures funding to advance skin cancer trials of novel ointment appeared first on Clinical Trials Arena.

]]>
Minghui Pharmaceutical’s MHB039A shows promise in Phase I trial for solid tumours https://www.clinicaltrialsarena.com/news/minghui-mhb039a-phase-i/ Thu, 07 Nov 2024 15:50:26 +0000 https://www.clinicaltrialsarena.com/news/minghui-mhb039a-phase-i/ Minghui Pharmaceutical has reported promising initial outcomes from its Phase I trial of MHB039A to treat patients with solid tumours.

The post Minghui Pharmaceutical’s MHB039A shows promise in Phase I trial for solid tumours appeared first on Clinical Trials Arena.

]]>
The post Minghui Pharmaceutical’s MHB039A shows promise in Phase I trial for solid tumours appeared first on Clinical Trials Arena.

]]>